Healthcare stocks in Canada

Intrinsic value and value investing analysis for healthcare stocks in Canada.

30 companies

Companies

• BLCO - Bausch + Lomb Corp: overvalued, -71% margin of safety
• ABCL - AbCellera Biologics Inc: overvalued, -1076% margin of safety
• XENE - Xenon Pharmaceuticals Inc: no published value
• BHC - Bausch Health Companies Inc: no reliable verdict
• AUPH - Aurinia Pharmaceuticals Inc: undervalued, +57% margin of safety
• CRON - Cronos Group Inc: overvalued, -25% margin of safety
• HELP - Helus Pharma Inc: no published value
• EPRX - Eupraxia Pharmaceuticals Inc: no published value
• TLRY - Tilray Brands Inc: no reliable verdict
• CGC - Canopy Growth Corp: overvalued, -153% margin of safety
• ACB - Aurora Cannabis Inc: overvalued, -21% margin of safety
• PROF - Profound Medical Corp: undervalued, +71% margin of safety
• HITI - High Tide Inc: not valued
• NGEN - NervGen Pharma Corp: no published value
• MSLE - Satellos Bioscience Inc: no published value
• CRDL - Cardiol Therapeutics Inc: no published value
• OGI - Organigram Global Inc: undervalued, +67% margin of safety
• ENGN - enGene Therapeutics Inc: no published value
• MIST - Milestone Pharmaceuticals Inc: not valued
• EDSA - Edesa Biotech Inc: no published value
• PMN - ProMIS Neurosciences Inc: no published value
• BCTX - BriaCell Therapeutics Corp: no published value
• QNTM - Quantum BioPharma Ltd: no published value
• OPTH - Optimi Health Corp: no published value
• PBM - Psyence Biomedical Ltd: no published value
• INM - InMed Pharmaceuticals Inc: overvalued, -1118% margin of safety
• LEXX - Lexaria Bioscience Corp: overvalued, -288% margin of safety
• MDCX - Medicus Pharma Ltd: no published value
• CMND - Clearmind Medicine Inc: no published value
• XRTX - XORTX Therapeutics Inc: no published value